Janus Henderson Investors US’s AMAG Pharmaceuticals AMAG Stock Holding History

Janus Henderson Investors US’s Portfolio AMAG Stock Details AMAG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	$18M	Sell	800,000 -2,466,618	-76%	-$59.1M	0.01%	621
2016 Q4	$114M	Sell	3,266,618 -233,163	-7%	-$6.97M	0.1%	265
2016 Q3	$85.8M	Buy	3,499,781 +277,142	+9%	+$6.93M	0.07%	331
2016 Q2	$77.1M	Buy	3,222,639 +538,322	+20%	+$12.3M	0.07%	342
2016 Q1	$62.8M	Buy	2,684,317 +29,168	+1%	+$692K	0.05%	379
2015 Q4	$80.2M	Buy	2,655,149 +840,126	+46%	+$27.1M	0.07%	322
2015 Q3	$72.1M	Buy	1,815,023 +1,061,551	+141%	+$65.9M	0.06%	339
2015 Q2	$52M	Buy	753,472 +146,423	+24%	+$9.21M	0.04%	439
2015 Q1	$33.2M	Buy	+607,049	New	+$28.9M	0.03%	533

Other funds holding AMAG

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Numeric Investors Boston, Massachusetts $13.7B AUM 28.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Janus Henderson Investors US's AMAG Position: Q1 2017 in Review

Janus Henderson Investors US reduced its AMAG Pharmaceuticals (AMAG) stake by 76% in Q1 2017, selling an estimated $59.1M and leaving 800,000 shares worth $18M. The position accounts for 0.01% of the portfolio, ranked #621.

Janus Henderson Investors US first reported a position in AMAG in Q1 2015 and has held it in 9 quarters since. The position peaked at $114M in Q4 2016. 185 funds tracked by Wall St. Rank hold AMAG as of Q1 2017.

Janus Henderson Investors US held 800,000 shares of AMAG Pharmaceuticals worth $18M as of Q1 2017.
Janus Henderson Investors US sold 2,466,618 AMAG Pharmaceuticals shares in Q1 2017, an estimated $59.1M.
AMAG Pharmaceuticals made up 0.01% of Janus Henderson Investors US's portfolio in Q1 2017, its #621 holding.
Janus Henderson Investors US first reported a position in AMAG Pharmaceuticals in Q1 2015 and has held it in 9 quarters since.
Janus Henderson Investors US's AMAG Pharmaceuticals position peaked at $114M in Q4 2016.
185 funds tracked by Wall St. Rank held AMAG Pharmaceuticals as of Q1 2017.

Based on Janus Henderson Investors US's 13F filing for Q1 2017, filed 16 May 2017.